A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis
Clinical trial NCT07233655 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07233655
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-19
- Primary completion
- 2026-04-21
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.